We are live on
!
Find out more
ALDR
Alder Biopharmaceuticals
ALDR
ALDR
Delisted
ALDR was delisted on the 21st of October, 2019.
145 hedge funds and large institutions have $1.11B invested in Alder Biopharmaceuticals in 2016 Q4 according to their latest regulatory filings, with 17 funds opening new positions, 65 increasing their positions, 38 reducing their positions, and 30 closing their positions.
New
Increased
Maintained
Reduced
Closed
333% more call options, than puts
Call options by funds: $2.78M | Put options by funds: $642K
71% more repeat investments, than reductions
Existing positions increased: 65 | Existing positions reduced: 38
0% more funds holding in top 10
Funds holding in top 10: 5 → 5 (0)
9% less funds holding
Funds holding: 159 → 145 (-14)
36% less capital invested
Capital invested by funds: $1.73B → $1.11B (-$620M)
43% less first-time investments, than exits
New positions opened: 17 | Existing positions closed: 30
Holders
145
Holders Change
-14
Holders Change %
-8.81%
% of All Funds
3.63%
Holding in Top 10
5
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.13%
New
17
Increased
65
Reduced
38
Closed
30
Calls
$2.78M
Puts
$642K
Net Calls
+$2.14M
Net Calls Change
+$10.3M
Top Buyers
Top Sellers
| 1 |
SIG
Senator Investment Group
New York
|
-$32.8M |
| 2 |
Citadel Advisors
Miami,
Florida
|
-$20.8M |
| 3 |
Marshall Wace
London,
United Kingdom
|
-$12.2M |
| 4 |
Asset Management One
Tokyo,
Japan
|
-$9.69M |
| 5 |
DCM
Driehaus Capital Management
Chicago,
Illinois
|
-$7.63M |
